Versant Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Versant Ventures/Activity

Versant Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Exit

Portfolio company Anokion ceased operations (out of business exit).

Anokion

AnokionVersant Ventures

pitchbook.comDEC 6, 2025

DEC 6, 2025

Investment

Co-led $65M Series A for Dualitas Therapeutics to advance bispecific antibodies for immune and inflammatory disease.

Dualitas Therapeutics

Dualitas Therapeutics

Versant Ventures

prnewswire.comSEP 16, 2025

SEP 16, 2025